17.05.2018
- US drugmaker Eli Lilly has agreed to buy Canada’s AurKa Pharma from TVM Capital Life Science, bringing back in-house experimental cancer drug AK-01. The drug, an Aurora kinase A...
26.01.2018
- By vote of 55 to 43, former Eli Lilly executive Alex Azar was confirmed by the US Senate as new Secretary of the Department of Health and Human Services (HHS) on Jan. 24. Azar...
10.01.2018
- Alex Azar, US President Donald’s Trump’s choice to head the Department of Health and Human Services (HHS), has faced from criticism from Democrats in the Senate Finance Committee...
14.11.2017
- US president, Donald Trump, has chosen Alex Azar, a former US president of drugmaker Eli Lilly, as his new Secretary of Health and Human Services (HHS). Azar will replace Tom Price...
09.11.2017
- The US Food and Drug Administration has approved a new drug developed by Eli Lilly to treat a common type of breast cancer. Verzenio is recommended both for women and men with HR...
23.10.2017
- In a deal that could lead to the development of five new cancer vaccines, US drugs giant Eli Lilly is investing in German biopharma CureVac. Lilly will make an equity investment of...
12.09.2017
- US pharmaceutical giant Eli Lilly has announced it will slash 3,500 positions – about 8% of its global 42,000-strong workforce up to the end of 2017. The cuts, part of a scheme to...
31.07.2017
- US pharma companies Eli Lilly and Nektar Therapeutics have signed an agreement to jointly develop the latter’s novel immunotherapy, NKTR-358, which could potentially treat a number...
